CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Drugs.com Clinical Trial Results
Original article

Agios Provides Update on Phase 2 Trial of Tebapivat in Sickle Cell Disease

Phase 2TebapivatNeutral
AI Analysis

Summary

Agios Pharmaceuticals announced topline results from a Phase 2 trial of Tebapivat for sickle cell disease treatment.

Clinical Trial Data

Phase

Phase 2

Importance:5/10
Sentiment:
0.00
rare_diseaseclinical_trialsickle_cell_disease
Related Companies

Read the original article

Published by Drugs.com Clinical Trial Results on July 21, 2026 3:07 AM

Read Original